488 related articles for article (PubMed ID: 28324028)
21. Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.
Beadling C; Patterson J; Justusson E; Nelson D; Pantaleo MA; Hornick JL; Chacón M; Corless CL; Heinrich MC
Cancer Med; 2013 Feb; 2(1):21-31. PubMed ID: 24133624
[TBL] [Abstract][Full Text] [Related]
22. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
[TBL] [Abstract][Full Text] [Related]
23. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
[TBL] [Abstract][Full Text] [Related]
24. Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.
Miettinen M; Lasota J
Int J Biochem Cell Biol; 2014 Aug; 53():514-9. PubMed ID: 24886695
[TBL] [Abstract][Full Text] [Related]
25. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
26. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract][Full Text] [Related]
27. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.
Miettinen M; Wang ZF; Sarlomo-Rikala M; Osuch C; Rutkowski P; Lasota J
Am J Surg Pathol; 2011 Nov; 35(11):1712-21. PubMed ID: 21997692
[TBL] [Abstract][Full Text] [Related]
28. Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST.
Urbini M; Astolfi A; Indio V; Nannini M; Schipani A; Bacalini MG; Angelini S; Ravegnini G; Calice G; Del Gaudio M; Secchiero P; Ulivi P; Gruppioni E; Pantaleo MA
Sci Rep; 2020 Nov; 10(1):19829. PubMed ID: 33199729
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal Stromal Tumors: The GIST of Precision Medicine.
Mei L; Smith SC; Faber AC; Trent J; Grossman SR; Stratakis CA; Boikos SA
Trends Cancer; 2018 Jan; 4(1):74-91. PubMed ID: 29413424
[TBL] [Abstract][Full Text] [Related]
30. Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Nishida T; Naito Y; Takahashi T; Saito T; Hisamori S; Manaka D; Ogawa K; Hirota S; Ichikawa H
Cancer Sci; 2024 Mar; 115(3):894-904. PubMed ID: 38178783
[TBL] [Abstract][Full Text] [Related]
31. Succinate dehydrogenase-deficient GISTs are characterized by IGF1R overexpression.
Chou A; Chen J; Clarkson A; Samra JS; Clifton-Bligh RJ; Hugh TJ; Gill AJ
Mod Pathol; 2012 Sep; 25(9):1307-13. PubMed ID: 22555179
[TBL] [Abstract][Full Text] [Related]
32. Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors.
Wagner AJ; Remillard SP; Zhang YX; Doyle LA; George S; Hornick JL
Mod Pathol; 2013 Feb; 26(2):289-94. PubMed ID: 22955521
[TBL] [Abstract][Full Text] [Related]
33.
Schipani A; Nannini M; Astolfi A; Pantaleo MA
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980917
[TBL] [Abstract][Full Text] [Related]
34. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
Baskin Y; Kocal GC; Kucukzeybek BB; Akbarpour M; Kayacik N; Sagol O; Ellidokuz H; Oztop I
Oncol Res; 2016; 24(1):41-53. PubMed ID: 27178821
[TBL] [Abstract][Full Text] [Related]
35. Classification of gastrointestinal stromal tumor syndromes.
Gopie P; Mei L; Faber AC; Grossman SR; Smith SC; Boikos SA
Endocr Relat Cancer; 2018 Feb; 25(2):R49-R58. PubMed ID: 29170162
[TBL] [Abstract][Full Text] [Related]
36. Genetic and epigenetic alterations of SDH genes in patients with sporadic succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Shi SS; Wang YF; Bao W; Ye SB; Wu N; Wang X; Xia QY; Li R; Shen Q; Zhou XJ
Pathol Int; 2019 Jun; 69(6):350-359. PubMed ID: 31273876
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic and molecular genetic study of 22 Korean cases.
Kang G; Park YS; Jung ES; Joo M; Kang MS; Ahn S; Kang GH; Kim KM
APMIS; 2013 Oct; 121(10):938-44. PubMed ID: 23755839
[TBL] [Abstract][Full Text] [Related]
38. Succinate dehydrogenase deficient gastrointestinal stromal tumor in a three month old boy with a fatal clinical course: a case report and review of literature.
Lv BB; Li JM; Yao ZG; Cheng XK; Ren FX; Su WJ; Qin YJ; Wang Z; Cao ZX
Diagn Pathol; 2021 Feb; 16(1):14. PubMed ID: 33612108
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
40. Dedifferentiation in SDH-Deficient Gastrointestinal Stromal Tumor: A Report With Histologic, Immunophenotypic, and Molecular Characterization.
Malik F; Santiago T; Bahrami A; Davis E; McCarville B; Newman S; Azzato EM; Davidoff AM; Brennan R; Ellison DW; Clay MR
Pediatr Dev Pathol; 2019 Oct; 22(5):492-498. PubMed ID: 31072206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
